CDAK
$13.29
Codiak Biosciences
($1.04)
(7.26%)
CDAK
Earnings Whisper ®
N/A
4th Quarter December 2021
Consensus:  ($0.93)
Revenue:  $2.27 Mil
Thursday
Feb 3
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when CDAK reports earnings?
Beat
Meet
Miss

Where is CDAK's stock price going from here?
Up
Flat
Down
Stock chart of CDAK
Analysts
Summary of analysts' recommendations for CDAK
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Codiak BioSciences Inc. is a clinical-stage biopharmaceutical company. It is focused on development of exosome-based therapeutics for spanning oncology, neuro-oncology, neurology, neuromuscular disease and infectious disease. Codiak BioSciences Inc. is based in CAMBRIDGE, Mass.